Biologic Drugs With Established Pharmaceutical Class: CD19-directed Cytolytic Antibody
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: CD19-directed Cytolytic Antibody
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viela Bio | UPLIZNA | inebilizumab-cdon | Injection | 761142 | 2020-06-11 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |